Recent News

• 06.02.2026 - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 05.28.2026 - Equillium to Participate in the 2026 Jefferies Global Healthcare Conference
• 05.20.2026 - Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis
• 05.13.2026 - Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights
• 05.01.2026 - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2026 - 8-K Current report
• 05.27.2026 - 144 Report of proposed sale of securities
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors